The Moving Average Convergence Divergence (MACD) for PBH turned positive on October 06, 2026. Looking at past instances where PBH's MACD turned positive, the stock continued to rise in 27 of 38 cases over the following month. The odds of a continued upward trend are 71%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PBH's RSI Oscillator exited the oversold zone, 24 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on PBH as a result. In 52 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.
Following a +2.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where PBH advanced for three days, in 170 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
PBH moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PBH crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PBH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
PBH broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PBH entered a downward trend on September 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. PBH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.160) is normal, around the industry mean (43.873). P/E Ratio (13.146) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (1.482) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.042) is also within normal values, averaging (178.797).
The Tickeron SMR rating for this company is 74 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PBH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The RSI Oscillator for VCRB moved out of oversold territory on October 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 12 similar instances when the indicator left oversold territory. In 9 of the 12 cases the stock moved higher. This puts the odds of a move higher at 75%.
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on VCRB as a result. In 25 of 43 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 58%.
The Moving Average Convergence Divergence (MACD) for VCRB just turned positive on October 09, 2026. Looking at past instances where VCRB's MACD turned positive, the stock continued to rise in 11 of 24 cases over the following month. The odds of a continued upward trend are 46%.
Following a +0.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where VCRB advanced for three days, in 93 of 188 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.
VCRB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VCRB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 37%.
The Aroon Indicator for VCRB entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
PBH | ||
|---|---|---|
OUTLOOK RATING 1..100 | 21 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 74 | |
PRICE GROWTH RATING 1..100 | 57 | |
P/E GROWTH RATING 1..100 | 49 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| PBH | VCRB | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 60% | 1 day ago 75% |
| Stochastic ODDS (%) | 1 day ago 48% | 1 day ago 31% |
| Momentum ODDS (%) | 1 day ago 63% | 1 day ago 58% |
| MACD ODDS (%) | 1 day ago 71% | 1 day ago 46% |
| TrendWeek ODDS (%) | 1 day ago 58% | 1 day ago 49% |
| TrendMonth ODDS (%) | 1 day ago 55% | 1 day ago 33% |
| Advances ODDS (%) | 3 days ago 53% | 1 day ago 49% |
| Declines ODDS (%) | 14 days ago 57% | 10 days ago 37% |
| BollingerBands ODDS (%) | 1 day ago 57% | 1 day ago 69% |
| Aroon ODDS (%) | 1 day ago 57% | 1 day ago 19% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PBH’s FA Score shows that 0 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PBH’s TA Score shows that 4 TA indicator(s) are bullish.
PBH (@Pharmaceuticals: Generic) experienced а +4.44% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.86%. For the same industry, the average monthly price growth was -3.86%, and the average quarterly price growth was +15.65%.
PBH is expected to report earnings on Nov 05, 2026.
A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TRTY | 31.81 | 0.12 | +0.36% |
| Cambria Trinity ETF (TRTY) | |||
| CORB | 28.17 | 0.04 | +0.14% |
| AB Core Bond ETF (CORB) | |||
| DVXP | 24.45 | N/A | N/A |
| Webs Defined Volatility Xlp ETF | |||
| DDTD | 21.05 | -0.01 | -0.05% |
| Innovator Equity Dual Directional 10 Buffer ETF - December (DDTD) | |||
| TSEL | 29.59 | -0.05 | -0.15% |
| Touchstone Sands Capital US Select Growth ETF (TSEL) | |||
A.I.dvisor indicates that over the last year, PBH has been loosely correlated with HLN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then HLN could also see price increases.
| Ticker / NAME | Correlation To PBH | 1D Price Change % | ||
|---|---|---|---|---|
| PBH | 100% | -1.02% | ||
| HLN - PBH | 37% Loosely correlated | -0.63% | ||
| PRGO - PBH | 35% Loosely correlated | -0.52% | ||
| AMPH - PBH | 32% Poorly correlated | -2.65% | ||
| ANIP - PBH | 31% Poorly correlated | -3.74% | ||
| ELAN - PBH | 29% Poorly correlated | -0.66% | ||
More | ||||
A.I.dvisor tells us that VCRB and PBH have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VCRB and PBH's prices will move in lockstep.
| Ticker / NAME | Correlation To VCRB | 1D Price Change % | ||
|---|---|---|---|---|
| VCRB | 100% | +0.06% | ||
| PBH - VCRB | 15% Poorly correlated | -1.02% | ||
| WS - VCRB | 0% Poorly correlated | +3.19% |